179 related articles for article (PubMed ID: 36683084)
41. Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex.
Niu J; Yue W; Le-Le Z; Bin L; Hu X
Oncotarget; 2017 Nov; 8(59):99784-99800. PubMed ID: 29245940
[TBL] [Abstract][Full Text] [Related]
42. Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder.
Matsuoka T; Araki M; Lin Y; Okamoto T; Gold R; Chihara N; Sato W; Kimura A; Tachimori H; Miyamoto K; Kusunoki S; Yamamura T
Neurol Neuroimmunol Neuroinflamm; 2024 Jan; 11(1):. PubMed ID: 37863660
[TBL] [Abstract][Full Text] [Related]
43. Transforming growth factor-β1 in regulatory T cell biology.
Moreau JM; Velegraki M; Bolyard C; Rosenblum MD; Li Z
Sci Immunol; 2022 Mar; 7(69):eabi4613. PubMed ID: 35302863
[TBL] [Abstract][Full Text] [Related]
44. Monoclonal antibody therapy for neuromyelitis optica spectrum disorder: current and future.
Lin J; Xue B; Li X; Xia J
Int J Neurosci; 2017 Aug; 127(8):735-744. PubMed ID: 27680606
[TBL] [Abstract][Full Text] [Related]
45. Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis.
Hou MM; Li YF; He LL; Li XQ; Zhang Y; Zhang SX; Li XY
Int Immunopharmacol; 2019 Oct; 75():105793. PubMed ID: 31401379
[TBL] [Abstract][Full Text] [Related]
46. Group 2 innate lymphoid cells suppress the pathology of neuromyelitis optica spectrum disorder.
Kong Y; Li HD; Wang D; Gao X; Yang C; Li M; Chang T; Liu Q
FASEB J; 2021 Nov; 35(11):e21856. PubMed ID: 34606651
[TBL] [Abstract][Full Text] [Related]
47. GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity.
Zimmer N; Trzeciak ER; Graefen B; Satoh K; Tuettenberg A
Front Immunol; 2022; 13():928450. PubMed ID: 35898500
[TBL] [Abstract][Full Text] [Related]
48. Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.
Liénart S; Merceron R; Vanderaa C; Lambert F; Colau D; Stockis J; van der Woning B; De Haard H; Saunders M; Coulie PG; Savvides SN; Lucas S
Science; 2018 Nov; 362(6417):952-956. PubMed ID: 30361387
[TBL] [Abstract][Full Text] [Related]
49. Expansion of IL-6
Barros PO; Dias ASO; Kasahara TM; Ornelas AMM; Aguiar RS; Leon SA; Ruiz A; Marignier R; Araújo ACRA; Alvarenga R; Bento CAM
J Neuroimmunol; 2017 Jun; 307():82-90. PubMed ID: 28495144
[TBL] [Abstract][Full Text] [Related]
50. Single-cell RNA sequencing reveals cell type-specific immune regulation associated with human neuromyelitis optica spectrum disorder.
Jiang Y; Dai S; Pang R; Qin L; Zhang M; Liu H; Wang X; Zhang J; Peng G; Wang Y; Li W
Front Immunol; 2024; 15():1322125. PubMed ID: 38440735
[TBL] [Abstract][Full Text] [Related]
51. Effects of Tocilizumab Therapy on Circulating B Cells and T Helper Cells in Patients With Neuromyelitis Optica Spectrum Disorder.
Liu Y; Zhang H; Zhang TX; Yuan M; Du C; Zeng P; Huang Z; Jia D; Yang G; Shi FD; Zhang C
Front Immunol; 2021; 12():703931. PubMed ID: 34394101
[TBL] [Abstract][Full Text] [Related]
52. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.
Li Y; Kim BG; Qian S; Letterio JJ; Fung JJ; Lu L; Lin F
J Immunol; 2015 Sep; 195(6):2648-56. PubMed ID: 26246140
[TBL] [Abstract][Full Text] [Related]
53. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.
Stockis J; Liénart S; Colau D; Collignon A; Nishimura SL; Sheppard D; Coulie PG; Lucas S
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10161-E10168. PubMed ID: 29109269
[TBL] [Abstract][Full Text] [Related]
54. Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells.
Satoh K; Kobayashi Y; Fujimaki K; Hayashi S; Ishida S; Sugiyama D; Sato T; Lim K; Miyamoto M; Kozuma S; Kadokura M; Wakita K; Hata M; Hirahara K; Amano M; Watanabe I; Okamoto A; Tuettenberg A; Jonuleit H; Tanemura A; Maruyama S; Agatsuma T; Wada T; Nishikawa H
Int Immunol; 2021 Jul; 33(8):435-446. PubMed ID: 34235533
[TBL] [Abstract][Full Text] [Related]
55. Combined Blockade of GARP:TGF-β1 and PD-1 Increases Infiltration of T Cells and Density of Pericyte-Covered GARP
Bertrand C; Van Meerbeeck P; de Streel G; Vaherto-Bleeckx N; Benhaddi F; Rouaud L; Noël A; Coulie PG; van Baren N; Lucas S
Front Immunol; 2021; 12():704050. PubMed ID: 34386010
[TBL] [Abstract][Full Text] [Related]
56. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
57. Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature.
Ikeguchi R; Shimizu Y; Suzuki S; Shimizu S; Kabasawa C; Hashimoto S; Masuda M; Nagane Y; Utsugisawa K; Suzuki Y; Takahashi T; Utsumi H; Fujihara K; Suzuki N; Uchiyama S
Clin Neurol Neurosurg; 2014 Oct; 125():217-21. PubMed ID: 25178916
[TBL] [Abstract][Full Text] [Related]
58. CD4+CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFβ / GARP-mediated mechanism.
Miller MM; Petty CS; Tompkins MB; Fogle JE
Virol J; 2014 Jan; 11():7. PubMed ID: 24438223
[TBL] [Abstract][Full Text] [Related]
59. Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis.
Ma J; Chen Y; Li T; Cao Y; Hu B; Liu Y; Zhang Y; Li X; Liu J; Zhang W; Niu H; Gao J; Zhang Z; Yue K; Wang J; Bao G; Wang C; Wang PG; Zou T; Xie S
Oncogene; 2024 Jun; 43(25):1930-1940. PubMed ID: 38698265
[TBL] [Abstract][Full Text] [Related]
60. Peripheral CD19
Ellrichmann G; Bolz J; Peschke M; Duscha A; Hellwig K; Lee DH; Linker RA; Gold R; Haghikia A
J Neurol; 2019 Jan; 266(1):57-67. PubMed ID: 30377816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
